Research ArticleAcute Lung Injury

Pazopanib ameliorates acute lung injuries via inhibition of MAP3K2 and MAP3K3

See allHide authors and affiliations

Science Translational Medicine  28 Apr 2021:
Vol. 13, Issue 591, eabc2499
DOI: 10.1126/scitranslmed.abc2499

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article